10. Schedule 1 – Notification Form to Deal in MVP Securities
Part A – For completion by Designated Person
|Name of Designated Person|
|Nature of agreement/dealing (sale/purchase/subscription)
|Proposed date of transaction (i.e. proposed completion date)|
I confirm that:
a) I am not in possession of any unpublished information which, if generally available, might materially affect the price or value of MVP Securities; and
b) the transaction in MVP Securities described above does not contravene the Share Trading Policy of Medical Developments International Ltd.
Part B – For completion by the Company Secretary/Chairman of the Board/Managing Director
a) the confirmations given by the Designated Person; and
b) in addition, that the proposed trading in MVP Securities described above does not fall within a Black Out Period during which time all Staff are prohibited from trading.
This acknowledgement expires 5 business days after the date that it has been provided.
The Designated Person must provide further notification of any dealing in MVP Securities occurring after the expiry of that 5 business day period (or any other dealing in MVP Securities which is otherwise not described in Part A above).
The completed form is to be sent to the Company Secretary or his/her delegator, if the Company Secretary wishes to deal in MVP Securities, the Chairman of the Board or the Managing Director.
11. Schedule 2 – Acknowledgment by Employee/Director
I have read and understood the document entitled Policy on Dealings in securities of
MVP (“Share Trading Policy”) and agree to be bound by and to comply with the Share Trading Policy.
Please return completed form to the Company Secretary